AXL and central nervous system cancer: Finally, ARL2 overexpression inhibits proliferation, as well as migration and tumorigenicity of glioma cells, through regulation of the receptor tyrosine kinase AXL, a known regulator of glioma tumorigenesis (Wang et al., 2018).